LIMK1 and colorectal carcinoma: Knockdown or inhibition of LIMK1 inhibits the proliferation of lung cancer, gastric cancer, colorectal cancer (CRC), and acute myeloid leukaemia (AML) cells, as well as the invasion motility of glioblastoma11,12,.18–20